View this post on Instagram Gilead Science's antiviral drug remdesivir has been given the green light by the Food and Drug Administration as the first officially approved COVID-19 treatment. The approval comes following new results published in the New England Journal of Medicine Thursday from Gilead's Phase 3 ACTT-1 trial, which demonstrated faster recovery times than previously reported for the treatment of adults hospitalized with mild-moderate or severe coronavirus cases. (Regram: @foxbusiness) Click the link in our bio for more on this story. A post shared by Fox News (@foxnews) on Oct 22, 2020 at 3:57pm PDT
Gilead Science's antiviral drug remdesivir has been given the green light by the Food and Drug Administration as the first officially approved COVID-19 treatment. The approval comes following new results published in the New England Journal of Medicine Thursday from Gilead's Phase 3 ACTT-1 trial, which demonstrated faster recovery times than previously reported for the treatment of adults hospitalized with mild-moderate or severe coronavirus cases. (Regram: @foxbusiness) Click the link in our bio for more on this story.
A post shared by Fox News (@foxnews) on Oct 22, 2020 at 3:57pm PDT
